BSECompany Update7 Oct 2026 · 7 Oct 2026, 11:02 am
Certificate under Regn 74(5) of SEBI (DP) Regulations, 2018 for quarter ended September 30, 2026
Titan Biotech Ltd · 524717
✦ AI Summary
Titan Biotech Ltd has submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming the dematerialization of securities for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Titan Biotech Ltd - 524717 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018